88089-94-5 Usage
Description
Methyl 3-nitro-4-bromomethylbenzoate is an organic compound that features a nitro group at the 3-position and a bromomethyl group at the 4-position on a benzene ring, with a methyl ester group attached. This chemical structure endows it with unique reactivity and properties that make it a versatile intermediate in organic synthesis.
Uses
Used in Organic Synthesis:
Methyl 3-nitro-4-bromomethylbenzoate is used as a reactant for the preparation of various complex organic molecules. Its presence allows for the creation of nitrobenzyl-substituted α-hydroxy esters, which are important in the synthesis of pharmaceuticals and other bioactive compounds.
Used in the Preparation of (Hydroxy)Oxindoles:
methyl 3-nitro-4-bromomethylbenzoate serves as a key intermediate in the synthesis of (hydroxy)oxindoles, which are structural motifs found in many natural products and biologically active molecules. The nitro and bromomethyl groups in methyl 3-nitro-4-bromomethylbenzoate facilitate the formation of these oxindole derivatives through a series of chemical reactions.
Used in the Synthesis of Benzosultams:
Methyl 3-nitro-4-bromomethylbenzoate is also utilized in the preparation of benzosultams, which are compounds with potential applications in medicinal chemistry. The synthesis of these compounds often involves the use of the bromomethyl group for subsequent reactions, such as nucleophilic substitution, to introduce various functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 88089-94-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,0,8 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 88089-94:
(7*8)+(6*8)+(5*0)+(4*8)+(3*9)+(2*9)+(1*4)=185
185 % 10 = 5
So 88089-94-5 is a valid CAS Registry Number.
88089-94-5Relevant articles and documents
NOVEL SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS D-AMINO ACID OXIDASE (DAAO) INHIBITORS
-
Paragraph 00266, (2018/04/13)
The present invention provides novel substituted benzimidazole derivatives used as DAAO inhibitors and for treatment and/or prevention of neurological disorders.
HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING
-
Page/Page column 111, (2019/01/10)
The present invention relates to compounds of formula (I). The compounds may be used to modulate the Stimulator of Interferon Genes (STING) protein and thereby treat diseases such as cancer and microbial infections. (I)
NOVEL COMPOUNDS
-
Page/Page column 137, (2014/10/03)
The present invention relates substituted N-biphenyl-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-biphenyl-carboxamides of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative disorder, as a sole agent or in combination with other active ingredients.
